To help pharmaceutical manufacturers to comply with DSCSA Saleable Returns requirements and learn how Smith Drug Company resolves saleable returns verification issues (specifically the negative verification responses), LSPediA now has…
Learn More
Recent Posts
Subscribe to the LSPediA Newsletter
DSCSA Update: Where We are Now and How to Prepare for What’s Next
Genetco Switched to LSPediA for Improved Operational Efficiency
LSPediA Shapes the Future of Pharmaceutical Serialization with OneScan 4.0 Release
Smith Drug Investigator Pilot Webcast
Past Event – AmerisourceBergen Investigator Pilot Webcast
LSPediA COVID-19 Advisory and Support